Kineta's Unattributed - VI Round

Kineta raised a round of funding on September 11, 2017.

Kineta is a nationally-recognized biotechnology company focused on developing leading edge therapeutics in three large high need therapeutic areas: autoimmune disease, viral disease and chronic pain. …

Articles about Kineta's Unattributed - VI Round: